Teikoku Swears Off Pay-For-Delay In Lidoderm Deal With AGs
Teikoku Pharma agreed Wednesday not to engage in pay-for-delay deals with generic-drug makers in an injunction that ends accusations by attorneys general in California, Delaware, Florida, Illinois and 18 other states...To view the full article, register now.
Already a subscriber? Click here to view full article